Kemnay Advisory Services’s ResMed RMD Stock Holding History

Kemnay Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13K	Buy	58 +5	+9%	+$1.25K	﹤0.01%	905
2025 Q4	$12.8K	Buy	+53	New	+$13.6K	﹤0.01%	684

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kemnay Advisory Services's RMD Position: Q1 2026 in Review

Kemnay Advisory Services increased its ResMed (RMD) stake by 9.4% in Q1 2026, buying an estimated $1.25K and bringing the position to 58 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Kemnay Advisory Services first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Kemnay Advisory Services held 58 shares of ResMed worth $13K as of Q1 2026.
Kemnay Advisory Services bought 5 ResMed shares in Q1 2026, an estimated $1.25K.
ResMed made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #905 holding.
Kemnay Advisory Services first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.